» Articles » PMID: 15325964

Neuroprotective Effect of H. Perforatum Extracts on Beta-amyloid-induced Neurotoxicity

Overview
Journal Neurotox Res
Publisher Springer
Specialty Neurology
Date 2004 Aug 25
PMID 15325964
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

In the present study we assessed the neuroprotective role of a Hypericum perforatum ethanolic extract and obtained fractions in amyloid-beta peptide (Abeta)((25-35))-induced cell death in rat cultured hippocampal neurons. Lipid peroxidation was used as a marker of oxidative stress by following the formation of TBARS in rat cortical synaptosomes, after incubation with ascorbate/Fe2+, alone or in the presence of EC97 effective concentrations of H. perforatum fractions. Induced lipid peroxidation was significantly inhibited by fractions containing flavonol glycosides, flavonol and biflavone aglycones, and by a fraction containing several phenols, mainly chlorogenic acid-type phenolics (21%, 77% and 98%, respectively). Lipid peroxidation evaluated after incubation with 25 microM Abeta(25-35), was significantly inhibited by H. perforatum extract. Cell viability was assessed by use of the Syto-13/PI assay. The total ethanolic extract (TE) and fractions containing flavonol glycosides, flavonol and biflavone aglycones, reduced Abeta(25-35)-induced cell death (65%, 58% and 59%, respectively). These results were further supported by morphological analysis of cells stained with cresyl violet. Peptide beta-amyloid(25-35) induced a decrease in cell volume, chromatin condensation and nuclear fragmentation, alterations not evident in the presence of the TE and fractions containing hypericins (hypericin concentration = 11.02 microM), or fractions containing flavonoids (quercetin concentration = 21.13 microM). Dendritic lesion, an evidence of neurodegeneration, was observed by neuronal staining with cobalt following insult with Abeta(25-35), but prevented after exposure to the peptide plus the fractions referred above. The results of the present paper suggest that H. perforatum extracts may be endowed with neuroprotective compounds able to prevent Abeta(25-35)-induced toxicity.

Citing Articles

Phytochemical Analysis, Biological Activities, and Docking of Phenolics from Shoot Cultures of L. Transformed by .

Tusevski O, Todorovska M, Petreska Stanoeva J, Gadzovska Simic S Molecules. 2024; 29(16).

PMID: 39202972 PMC: 11357161. DOI: 10.3390/molecules29163893.


Hypericum perforatum: a comprehensive review on pharmacognosy, preclinical studies, putative molecular mechanism, and clinical studies in neurodegenerative diseases.

Suryawanshi M, Gujarathi P, Mulla T, Bagban I Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(6):3803-3818.

PMID: 38175276 DOI: 10.1007/s00210-023-02915-6.


Attitudes Toward Psychological Disorders and Alternative Medicine in Saudi Participants.

Alegiry M, Hajrah N, Alzahrani N, Shawki H, Khan M, Zrelli H Front Psychiatry. 2021; 12:577103.

PMID: 33643086 PMC: 7907434. DOI: 10.3389/fpsyt.2021.577103.


Rutin as a Potent Antioxidant: Implications for Neurodegenerative Disorders.

Enogieru A, Haylett W, Hiss D, Bardien S, Ekpo O Oxid Med Cell Longev. 2018; 2018:6241017.

PMID: 30050657 PMC: 6040293. DOI: 10.1155/2018/6241017.


Neuroprotective Activity of Hypericum perforatum and Its Major Components.

Oliveira A, Pinho C, Sarmento B, Dias A Front Plant Sci. 2016; 7:1004.

PMID: 27462333 PMC: 4939296. DOI: 10.3389/fpls.2016.01004.


References
1.
Conforti F, Statti G, Tundis R, Menichini F, Houghton P . Antioxidant activity of methanolic extract of Hypericum triquetrifolium Turra aerial part. Fitoterapia. 2002; 73(6):479-83. DOI: 10.1016/s0367-326x(02)00162-4. View

2.
Nahrstedt A, Butterweck V . Biologically active and other chemical constituents of the herb of Hypericum perforatum L. Pharmacopsychiatry. 1997; 30 Suppl 2:129-34. DOI: 10.1055/s-2007-979533. View

3.
Ambrosio A, Silva A, Malva J, Mesquita J, Carvalho A, Carvalho C . Role of desensitization of AMPA receptors on the neuronal viability and on the [Ca2+]i changes in cultured rat hippocampal neurons. Eur J Neurosci. 2000; 12(6):2021-31. DOI: 10.1046/j.1460-9568.2000.00091.x. View

4.
Greeson J, Sanford B, Monti D . St. John's wort (Hypericum perforatum): a review of the current pharmacological, toxicological, and clinical literature. Psychopharmacology (Berl). 2001; 153(4):402-14. DOI: 10.1007/s002130000625. View

5.
Casley C, Land J, Sharpe M, Clark J, Duchen M, Canevari L . Beta-amyloid fragment 25-35 causes mitochondrial dysfunction in primary cortical neurons. Neurobiol Dis. 2002; 10(3):258-67. DOI: 10.1006/nbdi.2002.0516. View